Annual Lung SPORE Workshop (Abstract Submission)

75 submissions

Created	First Name	Last Name	Email	Phone	Select a Session Topic	Abstract Title	First Author First Name	First Author Last Name	Affiliation	List of Additional Authors	Your Abstract Submission	Upload Abstract	Special Characters Included?	Abstract Review Status	Operations
Sun, 03/10/2024 - 15:40	Patrick	Oh	patrick.oh@yale.edu		Session 3: Immuno-oncology	Real-World Practice Patterns of Immunotherapy, Chemotherapy, and Targeted Therapy with Radiation Therapy in Early-Stage Node-Negative Non-Small Cell Lung Cancer	Patrick	Oh	Yale School of Medicine	First Name: Alexander Last Name: Sasse Affiliation: Yale School of Medicine First Name: Nicholas Last Name: Wells Affiliation: Yale School of Medicine First Name: So Yeon Last Name: Kim Affiliation: Yale School of Medicine First Name: Sarah Last Name: Goldberg Affiliation: Yale School of Medicine First Name: Henry Last Name: Park Affiliation: Yale School of Medicine	Abstract_Submission.pdf	Oh_Yale_Session#3.docx16.72 KB	No	Approved to be a Speaker	View
Sun, 03/10/2024 - 14:15	Triparna	Sen	triparna.sen@gmail.com	9179723836	Session 4: Small Cell Lung Cancer	Transcriptional and epigenetic landscape of neuroendocrine transformation during emergence of resistance to targeted therapies in EGFR mutant lung adenocarcinoma.	Triparna	Sen	Icahn School of Medicine at Mount Sinai		Abstract_Submission.pdf	Sen_Mount Sinai_Session 4.docx15.01 KB	No	Approved to be a Poster Presenter	View
Sun, 03/10/2024 - 12:47	Jessie	Hao	jessie.hao@emory.edu	4705423594	Session 6: Cancer Biology	Co-occurring genomic alterations-guided in silico discovery of therapeutic vulnerability in lung adenocarcinoma	Jessie	Hao	Department of Pharmacology and Chemical Biology, Emory University School of Medicine	First Name: Xiulei Last Name: Mo Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine	Abstract_Submission.pdf	SPORE abstract.docx14.48 KB	No	Approved to be a Poster Presenter	View
Sun, 03/10/2024 - 03:47	Catherine	Meador	cbmeador@mgh.harvard.edu	9192603477	Session 4: Small Cell Lung Cancer	Detecting small cell transformation in patients with advanced EGFR mutant lung adenocarcinoma through epigenomic cfDNA profiling	Catherine	Meador	Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA	First Name: Talal Last Name: El Zarif Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Xintao Last Name: Qiu Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Ji-Heui Last Name: Seo Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Matthew Last Name: Davidsohn Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Hunter Last Name: Savignano Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Gitanjali Last Name: Lakshminaranan Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Heather Last Name: McClure Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: John Last Name: Canniff Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Brad Last Name: Fortunato Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Rong Last Name: Li Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Mandeep Last Name: Banwait Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA First Name: Karl Last Name: Semaan Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Marc Last Name: Eid Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Henry Last Name: Long Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Yin Last Name: Hung Affiliation: Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA First Name: Navin Last Name: Mahadevan Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: David Last Name: Barbie Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Matthew Last Name: Oser Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Zofia Last Name: Piotrowska Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA First Name: Toni Last Name: Choueiri Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Sylvan Last Name: Baca Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Aaron Last Name: Hata Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA First Name: Matthew Last Name: Freedman Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA First Name: Jacob Last Name: Berchuck Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA	Abstract_Submission.pdf	Meador et al_SPORE 2024 abstract.docx15.96 KB	No	Approved to be a Poster Presenter	View
Sat, 03/09/2024 - 14:37	McGarry	Houghton	houghton@fredhutch.org	2066673175	Session 3: Immuno-oncology	Targeting the CXCR1/2 axis inhibits neutrophil function, and not recruitment, in NSCLC	Jeff	Kwak	Fred Hutch	First Name: Xiaodong Last Name: Zhu Affiliation: Fred Hutch First Name: Helena Last Name: Nguyen Affiliation: Fred Hutch First Name: Naia Last Name: Kenney Affiliation: Fred Hutch First Name: Christina Last Name: Baik Affiliation: University of Washington First Name: McGarry Last Name: Houghton Affiliation: Fred Hutch	Abstract_Submission.pdf	Houghton_FredHutch_3.docx13.61 KB	No	Approved to be a Speaker	View
Sat, 03/09/2024 - 14:07	Roger	Kim	roger.kim@pennmedicine.upenn.edu	239-218-5328	Session 5: Early Detection and Screening	Rationale and Design of the Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary NodulES (ARCADES) Pragmatic Randomized Controlled Trial	Roger	Kim	Division of Pulmonary, Allergy and Critical Care, Department of Medicine, University of Pennsylvania, Philadelphia, PA	First Name: John Last Name: Salsini-Tobias Affiliation: Division of Pulmonary, Allergy and Critical Care, Department of Medicine, University of Pennsylvania, Philadelphia, PA First Name: Katharine Last Name: Rendle Affiliation: Department of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA First Name: Nandita Last Name: Mitra Affiliation: Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA First Name: Anil Last Name: Vachani Affiliation: Division of Pulmonary, Allergy and Critical Care, Department of Medicine, University of Pennsylvania, Philadelphia, PA	Abstract_Submission.pdf	kim_university_of_pennsylvania_session_5.docx14.2 KB	No	Approved to be a Speaker	View
Sat, 03/09/2024 - 12:58	Yuji	Shibata	yshibata@mdanderson.org	3462274948	Session 1: Oncogene-driven lung cancers and resistance to targeted therapies	Pan-HER inhibition overcomes feedback adaptation resistance to KRAS G12C inhibition in KRAS G12C mutant non-small cell lung cancer	Yuji	Shibata	Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center	First Name: Hibiki Last Name: Udagawa Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center First Name: Monique Last Name: Nilsson Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center First Name: Jacqulyne Last Name: Robichaux Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center First Name: Ana Last Name: Galan-Cobo Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center First Name: David Last Name: Molkentine Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center First Name: Junqin Last Name: He Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center First Name: Qian Last Name: Huang Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center First Name: Marcelo Last Name: Negrao Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center First Name: Xiaoxing Last Name: Yu Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center First Name: Alissa Last Name: Poteete Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center First Name: Qian Last Name: Yu Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center First Name: Ferdinandos Last Name: Skoulidis Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center First Name: John Last Name: Heymach Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center	Abstract_Submission.pdf	03.08.2024 YS Lung SPORE 2024.docx15 KB	No	Approved to be a Poster Presenter	View
Fri, 03/08/2024 - 21:20	Michael	Oh	michaeloh@mednet.ucla.edu	7169829966	Session 3: Immuno-oncology	Phase I trial of intratumoral administration of autologous CCL21 gene-modified dendritic cells combined with pembrolizumab reveals local and systemic immune activation in advanced NSCLC	Bin	Liu	UCLA	First Name: Aaron Last Name: Lisberg Affiliation: UCLA First Name: Michael Last Name: Oh Affiliation: UCLA First Name: Ramin Last Name: Salehi-Rad Affiliation: UCLA and VA Greater Los Angeles Health Care Center First Name: Linh Last Name: Tran Affiliation: UCLA and VA Greater Los Angeles Health Care Center First Name: Raymond Last Name: Lim Affiliation: UCLA First Name: Camelia Last Name: Dumitras Affiliation: UCLA First Name: Zhe Last Name: Jing Affiliation: UCLA First Name: Fereidoun Last Name: Abtin Affiliation: UCLA First Name: Robert Last Name: Suh Affiliation: UCLA First Name: Scott Last Name: Genshaft Affiliation: UCLA First Name: Scott Last Name: Oh Affiliation: UCLA First Name: Gregory Last Name: Fishbein Affiliation: UCLA First Name: Anita Last Name: Kaul Affiliation: UCLA First Name: Kanwarpal Last Name: Kahlon Affiliation: UCLA First Name: Shahryar Last Name: Ashouri Affiliation: UCLA First Name: Jay Last Name: Lee Affiliation: UCLA First Name: Kostyantyn Last Name: Krysan Affiliation: UCLA and VA Greater Los Angeles Health Care Center First Name: Jonathan Last Name: Goldman Affiliation: UCLA First Name: David Last Name: Elashoff Affiliation: UCLA First Name: Edward Last Name: Garon Affiliation: UCLA First Name: Steven Last Name: Dubinett Affiliation: UCLA and VA Greater Los Angeles Health Care Center	Abstract_Submission.pdf	LIU_UCLA_Session 3.docx22.94 KB	No	Approved to be a Poster Presenter	View
Fri, 03/08/2024 - 19:37	Boning	Gao	boning.gao@utsouthwestern.edu	2146484915	Session 6: Cancer Biology	New human cell line models for the study of pathogenesis of SARS-CoV-2 infection	Boning	Gao	UT Southwestern	First Name: Ian Last Name: Boys Affiliation: UT Southwestern First Name: Sara Last Name: El Zahed Affiliation: Icahn School of Medicine at Mount Sinai First Name: Kimberley Last Name: Avila Affiliation: UT Southwestern First Name: Long Shan Last Name: Li Affiliation: UT Southwestern First Name: Luc Last Name: Girard Affiliation: UT Southwestern First Name: Hyunsil Last Name: Park Affiliation: UT Southwestern First Name: Victor Last Name: Stastny Affiliation: UT Southwestern First Name: Kenneth Last Name: Huffman Affiliation: UT Southwestern First Name: Shreoshi Pal Last Name: Choudhuri Affiliation: UT Southwestern First Name: Kimberly Last Name: Batten Affiliation: UT Southwestern First Name: Matthew Last Name: Esparza Affiliation: UT Southwestern First Name: Benjamin Last Name: Drapkin Affiliation: UT Southwestern First Name: Lisa Last Name: Miorin Affiliation: Icahn School of Medicine at Mount Sinai First Name: Jerry Last Name: Shay Affiliation: UT Southwestern First Name: Wendy Last Name: Maury Affiliation: University of Iowa First Name: Beatriz Last Name: Fontoura Affiliation: UT Southwestern First Name: John Last Name: Schoggins Affiliation: UT Southwestern First Name: Adolfo Last Name: Garcia-Sastre Affiliation: Icahn School of Medicine at Mount Sinai First Name: John Last Name: Minna Affiliation: UT Southwestern	Abstract_Submission.pdf	Gao_UT Southwester_Sesson#6.docx15.37 KB	No	Approved to be a Poster Presenter	View
Fri, 03/08/2024 - 18:05	Monique (Presented by Heymach)	Nilsson	mnilsson@mdanderson.org	7137458407	Session 1: Oncogene-driven lung cancers and resistance to targeted therapies	Trastuzumab deruxtecan resistance can be mediated by payload resistance or secondary extracellular ERBB2 mutations but sensitivity to HER2 tyrosine kinase inhibitors is maintained	John	Heymach (Submitted by M. Nilsson)	MD Anderson Cancer Center	First Name: Xiuning Last Name: Le Affiliation: MDACC First Name: Junqin Last Name: He Affiliation: MDACC First Name: Xiaoxing Last Name: Yu Affiliation: MDACC First Name: Xiaofang Last Name: Huo Affiliation: UTSW First Name: Ashwani Last Name: Kumar Affiliation: UTSW First Name: Alissa Last Name: Poteete Affiliation: MDACC First Name: Qian Last Name: Huang Affiliation: MDACC First Name: Ralf Last Name: Kittler Affiliation: UTSW First Name: John Last Name: Heymach Affiliation: MDACC	Abstract_Submission.pdf	2024.3.8 Nilsson Heymach SPORE Abstract Enhertu resistance.docx14.5 KB	No		View
Fri, 03/08/2024 - 13:42	Shi-Yong	Sun	ssun@emory.edu		Session 1: Oncogene-driven lung cancers and resistance to targeted therapies	Inhibition of hTERT/telomerase/telomere as an important mechanism mediating therapeutic efficacy of third generation EGFR inhibitors in EGFR mutant lung cancer	Zhen	Chen	Emory University	First Name: Karin Last Name: Vallega Affiliation: Emory University First Name: Dongsheng Last Name: Wang Affiliation: Emory University First Name: Zhihan Last Name: Quan Affiliation: Xiangya Second Hospital First Name: Songqing Last Name: Fan Affiliation: Xiangya Second Hospital First Name: Qiming Last Name: Wang Affiliation: Henan Cancer Hospital First Name: Ticiana Last Name: Leal Affiliation: Emory University First Name: Ramalingam Last Name: Suresh Affiliation: Emory University	Abstract_Submission.pdf	Chen et al. Osi.hTERT LC 03072024SPORE.docx14.15 KB	No	Approved to be a Poster Presenter	View
Fri, 03/08/2024 - 13:42	Sampada	Chande	sampada.chande@yale.edu	6097722949	Session 6: Cancer Biology	Characterization of tumor-neuron communication in lung adenocarcinoma brain metastasis	Sampada	Chande	Department of Pathology, Yale University School of Medicine	First Name: Atsushi Last Name: Yamasaki Affiliation: Daiichi Sankyo Co., Ltd., Tokyo, Japan First Name: Don Last Name: Nguyen Affiliation: Department of Pathology, Yale University School of Medicine	Abstract_Submission.pdf	Chande_Yaleschoolofmedicine_Session6.docx13.82 KB	No	Approved to be a Speaker	View
Mon, 03/04/2024 - 17:35	Matthew	Oser	matthew_oser@dfci.harvard.edu	9174883166	Session 4: Small Cell Lung Cancer	Cyclin A/B RxL Macrocyclic Peptide Inhibitors as a Therapeutic Strategy for Small Cell Lung Cancers with High E2F Activity	Shilpa	Singh	Dana-Farber Cancer Institute	First Name: Catherine Last Name: Gleason Affiliation: Circle Pharma First Name: Min Last Name: Fang Affiliation: UT Southwestern First Name: Vishal Last Name: Khivansara Affiliation: UT Southwestern First Name: Shanhai Last Name: Xie Affiliation: UT Southwestern First Name: Yavuz Last Name: Durmaz Affiliation: Dana-Farber Cancer Institute First Name: Aniruddha Last Name: Sarkar Affiliation: Dana-Farber Cancer Institute First Name: Yasmin Last Name: Laimon Affiliation: BWH First Name: Varunika Last Name: Savla Affiliation: BWH First Name: James Last Name: Aggen Affiliation: Circle Pharma First Name: Li-Fen Last Name: Liu Affiliation: Circle Pharma First Name: Bernard Last Name: Levin Affiliation: Circle Pharma First Name: Evelyn Last Name: Wang Affiliation: Circle Pharma First Name: Sabina Last Name: Signoretti Affiliation: BWH First Name: Alexander Last Name: Spektor Affiliation: Dana-Farber Cancer Institute First Name: Constantine Last Name: Kreatsoulas Affiliation: Circle Pharma First Name: Rajinder Last Name: Singh Affiliation: Circle Pharma First Name: David Last Name: Earp Affiliation: Circle Pharma First Name: Pablo Last Name: Garcia Affiliation: Circle Pharma First Name: Deepak Last Name: Nijhawan Affiliation: UT Southwestern	Abstract_Submission.pdf	LungSPORE2024abstract_MatthewOser.docx15.19 KB	No	Approved to be a Speaker	View
Thu, 02/29/2024 - 15:57	Bluma	Lesch	bluma.lesch@yale.edu	203-737-1074	Session 6: Cancer Biology	Mechanisms of epigenetic sensitization to lung cancer risk	Benjamin	Walters	Yale University	First Name: Jianlei Last Name: Gu Affiliation: Yale University	Abstract_Submission.pdf	240228_lesch_spore_abstract.docx13.43 KB	No	Approved to be a Poster Presenter	View
Tue, 02/20/2024 - 09:01	May-Lucie	Meyer	may-lucie.meyer@mssm.edu		Session 4: Small Cell Lung Cancer, Session 6: Cancer Biology	DLL3 expression in early-stage SCLC: comparative analysis of IHC and mRNA ISH	May-Lucie	Meyer	Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA	First Name: Hui Last Name: Yu Affiliation: Medical Oncology, University ofColorado Anschutz Campus, Aurora, USA First Name: Zoltan Last Name: Lohinai Affiliation: OKTPI-Koranyi National Institute, Budapest, Hungary First Name: Grace Last Name: van Hyfte Affiliation: epartment of Population HealthScience and Policy, Icahn School of Medicine at Mount Sinai, New York, USA First Name: Fred Last Name: Hirsch Affiliation: Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA	Abstract_Submission.pdf	Meyer_TischCancerInstituteMountSinai_Session#4or6.docx19.5 KB	No	Approved to be a Poster Presenter	View